DEA Cannabis rescheduling

A Washington-based researcher has filed a lawsuit against the Drug Enforcement Administration (DEA), alleging multiple legal violations in the agency's process of rescheduling marijuana. As Forbes reported, the complaint, filed in the U.S. District Court for Western Washington, names the Department...

Village Farms International, Inc. (NASDAQ:VFF) has been selected as the only cannabis plant-touching operator to testify at the Drug Enforcement Administration's (DEA) Administrative Law Judge (ALJ) hearing on rescheduling cannabis. Out of 25 participants, Village Farms, a US-based leader in...

Three national leaders gathered Wednesday to discuss the impact of the Drug Enforcement Administration's historic move to reclassify cannabis as a less dangerous drug.  Removing marijuana from Schedule 1 – the same class as heroin, LSD, meth and ecstasy – to Schedule III along with...

This week the Drug Enforcement Administration (DEA) has reportedly called for cannabis to be reclassified from Schedule I to Schedule III of the US Controlled Substances Act. This was the first time in history the DEA announced such a move, and it came...